Intelligent Bio Completes Study to Support FDA 510(k) Submission

Intelligent Bio Solutions completed a usability study for its Intelligent Fingerprinting Drug Screening System confirming effective use by non-specialist operators. This milestone aligns with the company's plan to submit a 510(k) in Q3 2026 to enter the U.S. market.